Latest Period
Q4 2025
- Info
- Insider Trading
- Financials
- Holders
Security Snapshot
PRECIGEN, INC. - Common Stock (PGEN) Institutional Ownership
CUSIP: 74017N105
13F Institutional Holders and Ownership History from Q1 2016 to Q1 2026
Institutions Reporting
177
Shares (Excl. Options)
136,011,432
Price
$4.18
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.
- Type / Class
- Equity / Common Stock
- Symbol
- PGEN on Nasdaq
- Shares outstanding
- 353,007,843
- Price per share
- $3.87
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 136,011,432
- Total reported value
- $568,542,687
- % of total 13F portfolios
- 0%
- Share change
- +22,261,196
- Value change
- +$96,374,703
- Number of holders
- 177
- Price from insider filings
- $3.87
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- PGEN - PRECIGEN, INC. - Common Stock is tracked under CUSIP 74017N105.
- 177 institutions reported positions in Q4 2025.
- 3 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 177 to 19 between Q4 2025 and Q1 2026.
- Reported value moved from $568,542,687 to $3,572,063.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 177 institutions filings for Q4 2025.
Investment Quick Answers
What is CUSIP 74017N105?
CUSIP 74017N105 identifies PGEN - PRECIGEN, INC. - Common Stock in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 74017N105:
Significant Owners of PRECIGEN, INC. - Common Stock (PGEN) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Patient Capital Management, LLC | 10% | -24% | $150,508,424 | -$38,525,651 | 36,006,800 | -20% | Patient Capital Management, LLC | 31 Dec 2025 |
| Miller William H III | 9.2% | $154,936,259 | 34,051,925 | William H. Miller III Living Trust dated April 17, 2017 | 26 Jun 2025 | |||
| Point72 Asset Management, L.P. | 5.2% | $76,841,952 | 18,383,242 | Point72 Asset Management, L.P. | 22 Jan 2026 |
As of 31 Dec 2025, 177 institutional investors reported holding 136,011,432 shares of PRECIGEN, INC. - Common Stock (PGEN). This represents 39% of the company’s total 353,007,843 outstanding shares.
Top 25 Institutional Shareholders
The largest institutional shareholders of PRECIGEN, INC. - Common Stock (PGEN) together control 34% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Patient Capital Management, LLC | 5.3% | 18,673,466 | -29% | 3% | $78,055,089 |
| BlackRock, Inc. | 4.3% | 15,094,359 | +24% | 0% | $63,094,420 |
| Point72 Asset Management, L.P. | 3.9% | 13,724,141 | +401% | 0.09% | $57,366,909 |
| STATE STREET CORP | 3.1% | 10,824,860 | +141% | 0% | $45,247,915 |
| VANGUARD GROUP INC | 3% | 10,479,452 | +17% | 0% | $43,804,109 |
| TANG CAPITAL MANAGEMENT LLC | 1.6% | 5,617,500 | -55% | 1.2% | $23,481,150 |
| FMR LLC | 1.3% | 4,652,179 | +3888% | 0% | $19,446,108 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.3% | 4,462,078 | +16% | 0% | $18,653,479 |
| Diametric Capital, LP | 1.1% | 3,847,024 | +295% | 4.3% | $16,080,560 |
| Driehaus Capital Management LLC | 1% | 3,601,674 | +76% | 0.1% | $15,054,997 |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 1% | 3,600,195 | -1.8% | 5.5% | $15,048,815 |
| Occam Crest Management LP | 0.99% | 3,501,739 | +30% | 10% | $14,637,269 |
| CITADEL ADVISORS LLC | 0.92% | 3,249,684 | +21% | 0.01% | $13,583,679 |
| MORGAN STANLEY | 0.9% | 3,193,522 | +61% | 0% | $13,348,922 |
| SymBiosis Capital Partners, LLC | 0.85% | 3,000,000 | 0% | 13% | $12,540,000 |
| BANK OF AMERICA CORP /DE/ | 0.62% | 2,188,606 | -13% | 0% | $9,148,372 |
| GOLDMAN SACHS GROUP INC | 0.62% | 2,173,933 | +196% | 0% | $9,087,040 |
| NORTHERN TRUST CORP | 0.45% | 1,579,142 | +15% | 0% | $6,600,813 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.43% | 1,506,755 | +20% | 0% | $6,298,236 |
| Woodline Partners LP | 0.4% | 1,400,961 | 0.02% | $5,856,017 | |
| Boxer Capital Management, LLC | 0.39% | 1,375,000 | +62% | 1.3% | $5,747,500 |
| Parkman Healthcare Partners LLC | 0.28% | 1,002,826 | -52% | 0.4% | $4,191,813 |
| JPMORGAN CHASE & CO | 0.26% | 914,919 | +20% | 0% | $3,824,362 |
| UBS Group AG | 0.25% | 891,428 | +41% | 0% | $3,726,169 |
| BARCLAYS PLC | 0.25% | 865,378 | +56% | 0% | $3,617,281 |
Institutional Holders of PRECIGEN, INC. - Common Stock (PGEN) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 922,076 | $3,572,063 | +$216,862 | $3.87 | 19 |
| 2025 Q4 | 136,011,432 | $568,542,687 | +$96,374,703 | $4.18 | 177 |
| 2025 Q3 | 111,297,177 | $366,220,521 | +$89,540,533 | $3.29 | 165 |
| 2025 Q2 | 82,070,744 | $116,553,437 | +$2,653,090 | $1.42 | 146 |
| 2025 Q1 | 80,161,429 | $119,337,253 | +$7,804,799 | $1.49 | 137 |
| 2024 Q4 | 75,787,342 | $84,752,627 | +$1,018,038 | $1.12 | 130 |
| 2024 Q3 | 74,934,960 | $70,966,781 | +$13,973,301 | $0.95 | 123 |
| 2024 Q2 | 60,722,436 | $95,930,395 | -$1,354,697 | $1.58 | 130 |
| 2024 Q1 | 61,605,921 | $89,315,893 | -$1,244,521 | $1.45 | 127 |
| 2023 Q4 | 62,597,104 | $83,879,140 | +$2,482,228 | $1.34 | 136 |
| 2023 Q3 | 60,552,257 | $85,976,957 | +$4,927,378 | $1.42 | 135 |
| 2023 Q2 | 57,391,361 | $65,981,492 | -$3,631,686 | $1.15 | 137 |
| 2023 Q1 | 61,459,047 | $65,137,179 | +$19,788,601 | $1.06 | 155 |
| 2022 Q4 | 42,284,714 | $64,263,385 | -$330,510 | $1.52 | 157 |
| 2022 Q3 | 125,018,911 | $265,021,859 | -$18,455,826 | $2.12 | 151 |
| 2022 Q2 | 135,952,580 | $182,176,824 | -$10,848,844 | $1.34 | 154 |
| 2022 Q1 | 143,469,817 | $302,712,530 | +$212,819 | $2.11 | 159 |
| 2021 Q4 | 142,860,197 | $529,867,886 | +$12,686,695 | $3.71 | 157 |
| 2021 Q3 | 138,272,261 | $690,254,065 | -$19,066,872 | $4.99 | 162 |
| 2021 Q2 | 142,052,644 | $926,165,482 | -$505,170 | $6.52 | 142 |
| 2021 Q1 | 142,033,611 | $978,581,859 | +$140,930,422 | $6.89 | 154 |
| 2020 Q4 | 121,129,113 | $1,235,480,007 | -$19,579,424 | $10.20 | 142 |
| 2020 Q3 | 123,718,445 | $433,031,361 | +$6,466,151 | $3.50 | 145 |
| 2020 Q2 | 121,163,398 | $604,513,971 | -$28,168,416 | $4.99 | 134 |
| 2020 Q1 | 129,153,759 | $439,106,078 | +$437,977,926 | $3.40 | 134 |
| 2019 Q4 | 227,607 | $1,148,000 | +$636,000 | $5.48 | 4 |
| 2019 Q3 | 42,862 | $279,000 | $6.51 | 1 | |
| 2019 Q2 | 42,862 | $279,000 | $6.51 | 1 | |
| 2019 Q1 | 42,862 | $279,000 | $6.51 | 1 | |
| 2016 Q2 | 0 | $0 | -$12,709 | $3.87 | 0 |
| 2016 Q1 | 375 | $12,709 | $33.89 | 1 |